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Original Article
Pre-operative renal function and selective renal vein rennin levels as markers of
favourable outcome in renovascular hypertension
Malik Anas Rabbani1, Alia Zaidi2, Bushra Ahmad3, Syed Sohail Ali4, Asmooni Younus5, Zaid Soofi6, 
Syed Mansoor Ahmad Shah7
Department of Nephrology1,7, The Kidney Center Postgraduate Training Institute, Departments of Medicine2-5, and Surgery6, Aga Khan University
Hospital, Karachi.
Abstract
Objective: To evaluate factors that affect outcome following revascularization in patients with renovascular
hypertension.
Methods: This study was conducted at the Aga Khan University Hospital. It included all the patients diagnosed
to have Renovascular hypertension confirmed by renal angiography between July 1996 to September 2000.
Using ANOVA (Analysis of variance) and paired-sample t-test, several preoperative factors were evaluated for
their ability to predict postoperative improvement of blood pressure and renal function.  For descriptive purpose
patients were divided into cured, improved and failure groups. 
Results: Of the total 15 patients, 9 were males and 6 were females. Before the surgical procedure, 13 patients
were on 3 or more antihypertensive drugs. Eleven patients received vein grafts, three patients had PTFE (poly-
tetraflouroethyline) grafts while one patient underwent angioplasty and stenting. The patients had a median fol-
low-up period of nine months with a range of 2 to 84 months. Five were completely cured, as they became nor-
motensive without antihypertensive therapy after operation, whereas four showed marked improvement in BP
control postoperatively, requiring two antihypertensive drugs. Six patients showed no improvement requiring 3 or
more drugs. Extended cure or improvement of renovascular hypertension was achieved in nine patients. Normal
preoperative serum creatinine level, high preoperative unstimulated peripheral renin levels and renal vein renin
ratio of at least 1.75:1 were the most significant predictive factors for favorable outcome.
Conclusion: This study confirms the long term effectiveness and safety of renovascular reconstruction in the
relief of severe hypertension. The results further suggest that normal preoperative renal function, high renal vein
renin ratio and high preoperative unstimulated peripheral renin levels are associated with the most favourable
postoperative outcome (p <0.01).  Preoperative severity and duration of hypertension and degree of disparity in
kidney sizes do not affect the overall results in terms of postoperative improvement in renal function and blood
pressure control (p=0.734) (JPMA 57:178;2007).
Introduction
Renovascular hypertension is one of the most common
potentially curable types of secondary hypertension.1 The
exact prevalence of renovascular hypertension in the gener-
al population is not known and diagnosis is missed in many
patients.2 It is important to diagnose it at an early stage
since it is the most common curable form of hypertension
and is one of the few potentially reversible causes of chron-
ic renal failure.1 Preponderance of experimental data sug-
gests that the mechanism of hypertension in renovascular
disease is produced by stimulation of renin-angiotensin sys-
tem. 
About 80% of patients require less medication for
hypertension after angioplasty or operation3 whereas about
30% of all patients require no antihypertensive therapy after
the procedure.4 Approximately two-thirds of patients have
arterial changes due to atherosclerosis and almost one third
have changes due to fibromuscular dysplasia. Untreated
cases of renovascular disease indefinitely progress to wors-
ening of renal function and high cardiovascular morbidity
and mortality.5,6 Medical therapy in general does not inhib-
it progressive loss of renal function.6-8 Once renal artery is
stenosed more than 70%, revascularization is indefinitely
required. Renal revascularization performed in such cases
not only prevents or reverses renal failure but also results in
adequate blood pressure control5 and significantly
improved  survival  in these patients compared with a com-
parable-age matched population.5,9 There has never been a
prospective randomized comparison of PTA and recon-
structive procedures. However all retrospective compar-
isons have found surgical results to be superior to PTA for
patients with atherosclerotic disease, whereas patients with
fibrodysplastic lesions responded well to either therapy.
Surgical revascular procedures are not without risk. Overall
mortality is about 5%, and major complication rate is
approximately 10%.10 We conducted this study to evaluate
factors that affect common following revascularization in
patients with renovascular hypertension. In order to define
which patients will get benefit from revascularization pro-
cedure and hence to avoid un-necessary risks associated
with surgery.
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Patients and Methods
This study was conducted at the Aga Khan University
Hospital. It included all the patients diagnosed to have ren-
ovascular hypertension confirmed by renal angiography
between 1997 to 2000. Record files were reviewed in terms
of age, sex, clinical presentation, laboratory investigations
including S.Creatinine, electrolytes, Ultrasound kidneys,
duplex scan, captopril DTPA scan and conventional angiog-
raphy. Pre and post operative blood pressure recordings,
renal function and renal and peripheral venous samples for
renin estimation were also assessed. All the data was ana-
lyzed using SPSS version (Release 8.0, standard version,
copyright SPSS; 1989-97). Using ANOVA (Analysis of
variance) and paired-sample t-tests, several preoperative
factors including duration of hypertension at the time of
presentation, renal vein renin ratio (affected versus non-
affected kidney), disparity in kidney sizes, renal function at
the time of presentation and unstimulated peripheral renin
levels were analyzed for their ability to predict postopera-
tive improvement of blood pressure and renal functions.
For descriptive purpose patients were divided into
cured, improved and failure groups. Cure was defined as
normalization of renal function and blood pressure without
any anti-hypertensive therapy.
Improvement was defined as > 20 % decrease in post
operative S. Creatinine and post-operative blood pressure of
< 160/100 mmHg, but greater than 140/90 mm of Hg.
Failure was defined as rise in S. Creatinine of >20%
as compared to preoperative levels and blood pressure of
>160/100 mmHg in the postoperative phase.
Patients with extrinsic compression of renal arteries
or stenosis of renal grafts were excluded.
Results
Summarized in Table 1 are clinical and biochemical
data from 15 patients with Renovascular hypertension who
were subsequently operated upon and followed up for a
period of 9 months (median) with the range from 2 to 84
months. Among 15 patients, 9 were males and 6 were
females. Eleven patients received vein grafts, three
received PTFE (polytetraflouroethyline) grafts while one
patient underwent angioplasty and stenting. According to
the criteria set before starting the study, 5 patients were
cured, 4 showed marked improvement while 6 patients
showed no improvement. Mean age in the cured group was
45 years (range 15-64 years), in improved group, 30 years
(range 22-38) and in failure group it was 35 years (Range
27-52 years). 
In the cured group renal function was normal in 3
patients at the time of presentation and impaired in 2
patients. After surgical intervention renal function normal-
ized in one while in the others it showed marked improve-
ment over a period of 9 months. 
In the improved group, Serum Creatinine (S. Cr) was
high in three patients (range 1.7-3.9) and normal in one
patient at the time of presentation. Of the three patients with
high S.Cr at presentation two showed marked improvement
while in third patient renal function became normal postop-
eratively.
Sr. No. Age(Years) Sex
Pre-operative Post-operative Disparity
in kidney
size cm
Peripheral
renin level
ng/ml/hr
Renal vein
renin ratio
(RVRV)
Duration
of  HTN
Years
Mean FU
(Months)
Site of
lesion OutcomeBP
mmHg
S.Cr
mg/dl
BP
mmHg
S.Cr
mg/dl
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
54
50
64
43
15
28
38
22
31
27
41
52
30
27
40
F
M
M
F
M
F
M
M
M
F
M
F
F
M
M
246/130
160/110
165/105
180/100
160/110
270/140
230/130
220/140
160/105
190/110
235/130
180/110
180/100
170/110
170/80
1.2
1.1
2.7
1.5
0.7
3.9
1.0
1.7
1.8
2.1
2.8
2.5
0.8
1.6
0.9
120/80
125/70
110/80
135/65
110/65
150/85
145/90
140/95
150/80
230/130
220/140
180/100
140/98
170/80
160/110
1.1
1.1
2.5
1.0
0.7
3.6
1.0
1.0
1.7
2.2
2.8
4.0
1.8
2.9
2.7
2.0
3.0
4.0
2.3
3.2
2.8
2.6
2.2
2.5
3.0
2.8
0.0
2.2
2.1
4.1
8.6
10.0
11.3
8.2
15.5
14.40
15.9
19.7
10.0
5.1
5.3
4.8
4.1
6.0
5.2
2.73:1
2.50:1
2.60:1
2.80:1
5.50:1
2.20:1
1.90:1
2.00:1
1.75:1
0.78:1
0.83:1
1.10:1
0.51:1
0.68:1
1.1: 88
7
6
4
5
2.6
6
16
2
0.8
0.4
8
12
0.8
2
30
84
9
9
24
6
12
24
32
2
51
5
12
0
0
6
L
R
R
R
L
L
L
R
R
L
R
R+L
L
R
R+L
Cure
Cure
Cure
Cure
Cure
Improved
Improved
Improved
Improved
Failure
Failure
Failure
Failure
Failure
Failure
Table 1. Pre and postoperative features of Renovascular Hypertension.
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Four patients in the failure group had high S.Cr inicially
(mean 2.5 mg, range 1.6-2.5 mg) and these four patients
showed further worsening over an average period of 17
months. In the remaining two patients in whom renal func-
tion was normal at the time of presentation, it deteriorated
over an average period of four months. The blood pressure
remained uncontrolled in one patient who refused to under-
go surgery and showed deterioration of renal function over
a period of six months.
The mean preoperative BP was 183/111mm Hg in
the cured group, 220/128 mmHg in improved group and
188/106 mmHg in the failure group. Mean duration of
hypertension was 60 months, 74 months and 106 months in
the groups respectively. 
The mean postoperative BP in the cured group was
120/70 mmHg, 145/88 mmHg in the improved group and
183/110 mmHg in the failure group.
The mean disparity in kidney size was 2.9 cm
(Range 2-4) in the cured group, 2.5 cm in improved group,
and 2.33 cm (Range 0.0 - 4.10) in the failure group. 
The mean renal vein rennin ratio (affected versus
non affected kidney) was 3.23:1 (range 2.50-5.50: 1) in the
cured group, 1.96:1 (range 1.75-2.2: 1) in the improved
group and 0.83:1 (range 0.51-1.1: 1) in the failure group.
The mean peripheral rennin level was 10.72 ng/ml/hr
/ (Range 8.2-15.5) in the cured group, 15.2 ng/ml/hr (range
10.0-19.7) in the improved group and 5.13 ng/ml/hr  (range
4.1-6) in the failure group. 
Discussion
Renovascular hypertension is the most common cur-
able form of high blood pressure. Several new concepts
have emerged in recent years relative to atherosclerotic
renal artery stenosis. Most notably, the indications for inter-
vention have changed.5,6 The enhanced efficacy of medical
anti-hypertensive therapy has decreased the number of
patients who require intervention solely to treat renovascu-
lar hypertension. On the other hand, recent studies of the
natural history of atherosclerotic renal artery stenosis have
shown that progressive vascular obstruction occurs com-
monly in patients treated medically and in most of cases
leads to deterioration of renal function.7 This information
has reinforced the importance of relieving renal arterial
obstruction to preserve renal function in these patients.7
However, in some patients with atherosclerotic renovascu-
lar disease, it is difficult to determine whether the hyperten-
sion is truly renovascular or the progression of atherosclero-
sis due to long standing hypertension caused the renal artery
stenosis. Thus, more extensive investigations, particularly
in elderly patients, may be necessary to confirm the reno-
vascular mechanism of hypertension before surgical treat-
ment is recommended. While patients with atherosclerotic
renal artery stenosis were formerly considered high risk
candidates for operative therapy8, it has been demonstrated
that surgical revascularization can now be done safely and
successfully even in older patients with extensive extra-
renal vascular disease.9-11 This has been accomplished pre-
dominately through vigorous preliminary screening and
correction of existing coronary or cerebrovascular occlusive
disease. In addition, the development of more effective
techniques for surgical revascularization has made possible
operating even on a badly diseased abdominal aorta.12 In
our study, the long-term clinical outcome following surgical
revascularization in terms of blood pressure response and
post-operative renal function was evaluated. Extended cure
or improvement of RVH was achieved in 60% of patients
with low pre-operative S.Cr level, renal vein renin ratio of
at least 1.75:1 and high unstimulated peripheral renin levels,
all of which constituted significant predictive factors for the
outcome (p <0.012).
Of the 15 patients in the series, 33% were complete-
ly cured, as they became normotensive after operation with-
out anti-hypertensive therapy, while 27% showed marked
improvement in blood pressure control post-operatively
needing fewer medications. These results compare
favourably to those of Laurie et al who noted a favorable
blood pressure response to surgical revascularization in
82% of 919 patients, followed-up for a period of six years.13
However, when both kidneys are involved the situation
becomes more complex as there is no normal kidney to
excrete the retained sodium and water. In such patients, the
renin and aldosterone levels may become normal but hyper-
tension persists because of the increased plasma volume. In
a compilation of 58 different series of patients, Rudnik et al
calculated a sensitivity of 80% and specificity of 62% for
renal vein renin ratio.14 Our study has shown that individu-
als with renal vein renin ratio of at least 1.75:1 have either
marked improvement or complete cure. Disparity in kidney
sizes as well as severity and duration of hypertension did
not affect the overall post-operative results.
Conclusion
Our study confirmed that long term safety and effi-
cacy of renovascular reconstruction for the treatment of
severe hypertension. Most favourable results were obtained
in cases with normal pre-operative renal function, high renal
vein rennin ratio and high preoperative unstimulated periph-
eral rennin levels. 
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